Hepatology International-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2022-07-01 是技师不是医师

无

48 0

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2022-06-10 是技师不是医师

审稿速度:2.0
经验分享：wu

43 0

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2021-12-28 Mia

老牌期刊和新出版期刊是否都要选一些？

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2021-12-27 衣谷

两个IF相当的期刊，如何选择要投哪个？

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2021-01-20 1dd96cb3m86(暂无匿称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：肝癌放疗投稿一月大修，期待好运

110 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2021-04-14 735766106

去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。

93 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2018-07-27 landayb@163.com

审稿速度:3.0 | 投稿命中率:25.0
经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐

110 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2020-08-21 痞子孙小兵

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肝癌;放疗;手术
经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。

134 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

不知道怎么说

211 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229964, encodeId=0b8b122996481, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jul 01 15:30:42 CST 2022, time=2022-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225680, encodeId=bc331225680d9, content=审稿速度:2.0 经验分享：wu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21975472039, createdName=是技师不是医师, createdTime=Fri Jun 10 17:02:29 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100689, encodeId=07781100689a3, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100690, encodeId=86bc11006908f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918251, encodeId=415e9182514b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：肝癌放疗投稿一月大修，期待好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Wed Jan 20 06:57:50 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956842, encodeId=27c795684297, content=去年12月投稿，4月接收，经历了大修，小修，总体感觉reviewer很认真，但比较好说话。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0652638163, createdName=735766106, createdTime=Wed Apr 14 10:57:56 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559626, encodeId=584555962608, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：不是很推荐，审稿慢，而且编辑意见很繁琐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c00e1679674, createdName=landayb@163.com, createdTime=Fri Jul 27 21:36:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811857, encodeId=1f6281185ec1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝癌;放疗;手术 经验分享：刚投了一篇，一审大概一个月，5个审稿人，2个没提意见，2个人提了4-5条修改意见，1个主审稿人提了近20条意见。做的两种治疗比较的匹配分析。大修之后7月20日返回，8月20日刚收到接收的邮件。审稿人非常认真、仔细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLEOiakaK8sYGAHicGEcRAQJm5kFbrR1MfFmlHuiaIb19JPJB28QibuEDJ5081W10d0NJiaL4Wf5mblq0Q/0, createdBy=03ec2202191, createdName=痞子孙小兵, createdTime=Fri Aug 21 17:00:50 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578808, encodeId=e1015e880801, content=不知道怎么说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529284, encodeId=2800529284b5, content=刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=933b1738737, createdName=1df04824m88(暂无匿称), createdTime=Sat Nov 12 23:40:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

2016-11-12 1df04824m88(暂无匿称)

刚收到大修的意见，审稿人真的非常非常认真，基本逐字逐句看的，要好好忙活一下了！

305 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务